US Pharm. 2009'34(4):8.

Nutley, NJ -- When the ink dries on Roche's $46.8 billion purchase of Genentech, as many as 400 manufacturing jobs could be cut from its Nutley campus despite the fact that Roche was awarded $1.4 million in state tax credits in 2007 to maintain its New Jersey workforce. The company said that while the manufacturing operations in Nutley would likely close next year, it plans to reposition the facility to focus on cancer treatment and research and development. A number of administrative, marketing, and other positions will be transferred to Genentech's South San Francisco location. The deal, which accounts for the 44% of Genentech that Roche does not currently own, still needs shareholder approval.